 |
| Stefan Borgas | Chief Executive Officer |
|---|---|
| Uwe H. Böhlke | Chief Officer Human Resources / Corporate Services |
| Stephan Kutzer | COO Custom Manufacturing division |
| Stefan Borgas | COO Life Science Ingredients division |
| Lukas Utiger | COO Bioscience division |
| Toralf Haag | Chief Financial Officer |
Divisions
| Custom Manufacturing (formerly Exclusive Synthesis & Biopharmaceutcals) |
| Life Science Ingredients |
| Bioscience |
Group Functions
| Global HR / Corporate Services | Legal | Corporate Development | Corporate Communications | Formulated Products |
| Key figures (million CHF) | 2008 | 2009 | 2009 |
|---|---|---|---|
| before special charges | after special charges 1 | ||
| Net sales | 2937 | 2690 | 2690 |
| Operating income | 441 | 380 | 239 |
| Net income | 419 | 279 | 159 |
| Cash flow before change in net working capital | 530 | 472 | 468 |
| Net debt | 1469 | 1166 | 1166 |
| Investments in property, plant and equipment | 420* | 511* | 511* |
| Number of employees | 8462 | 8386 | 8386 |
|
*excluding customer financial 1Special charges: - Impairment of assets (83) - Write-down of inventories (22) - Restructuring expenses (25) - Environmental expenses (11) - Total special charges (141) |
| Sales by operating segments (million CHF) | 2008 | 2009 |
|---|---|---|
| Custom Manufacturing | 1512 | 1418 |
| Life Science Ingredients | 1196 | 1038 |
| Bioscience | 222 | 231 |
| Corporate | 3 |
